Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
INNV · against 470 other Healthcare companies of similar size
Ranked #223 of 471 · scores higher than 53% of peers · safety percentile 57
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)51 peers with a safety percentile of 50–59, including INNV · Click a bar to see the companies
A mix: stronger beta, but weaker current ratio than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | INNV | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 444 reported | 0.32× | 0.20× | 38% | 33% | |
| BetaLower is better · 444 reported | 0.15 | 0.49 | 80% | 33% | |
| Current ratioHigher is better · 457 reported | 1.05× | 2.88× | 9% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 1.5B USD | 100 | 44 | |
| 2 | 1.2B USD | 100 | 40 | |
| 3 | 1.1B USD | 100 | ||
| 4 | 1.0B USD | 99 | 35 | |
| 5 | 1.2B USD | 99 | ||
| 219 | 4.5B CNY (≈$633M) | 57 | 65 | |
| 220 | 2.1B USD | 57 | 61 | |
| 221 | 2.4B USD | 57 | 20 | |
| 222 | 1.3B USD | 57 | 58 | |
| 223 | 1.2B USD | 57 | 49 | |
| 224 | 7.2B CNY (≈$1.0B) | 57 | 56 | |
| 225 | 6.8B HKD (≈$872M) | 57 | 78 | |
| 226 | 6.0B CNY (≈$840M) | 56 | 35 | |
| 227 | 143.1B JPY (≈$973M) | 56 | 75 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score